Table 3.
Study Quality Assessment
| Author | Representativeness | Ascertainment of exposure | Ascertainment: two reviewers with IRR reported | Ascertainment: criteria for preventability specifically defined | Outcome not present at start of the study | Assessment of outcome | Was follow-up long enough? | NOS |
|---|---|---|---|---|---|---|---|---|
| Random or consecutive cohorts | ||||||||
| Engel,15 2007 | * | * | – | * | * | * | * | 6/7 |
| Hogan,16 2012 | * | * | * | * | * | * | * | 7/7 |
| Sorinola,17 2012 | * | * | – | * | * | * | * | 6/7 |
| Baines,18 2015 | * | * | * | * | * | * | * | 7/7 |
| Hogan,19 2015 | * | * | * | * | * | * | * | 7/7 |
| Flaatten,20 2017 | * | * | – | * | * | * | * | 6/7 |
| Kobewka,21 2017 | * | * | * | * | * | * | * | 7/7 |
| Rogne,22 2019 | * | * | – | * | * | * | * | 6/7 |
| Selected cohorts and comparable definitions of preventable | ||||||||
| Dubois,23 1988 | – | * | * | * | * | * | * | 6/7 |
| Hayward,24 2001 | – | * | * | * | * | * | * | 6/7 |
| Ksouri,25 2010 | – | * | – | * | * | * | * | 5/7 |
| Goulet,26 2015 | – | * | * | * | * | * | * | 6/7 |
| Roberts,27 2017 | – | * | – | * | * | * | * | 5/7 |
| Selected cohorts and different definitions of preventable | ||||||||
| Best,28 1994 | – | * | * | * | * | * | * | 6/7 |
| Lu,29 2006 | – | * | * | – | * | * | * | 5/7 |
| Klein,30 2017 | – | * | – | – | * | * | * | 4/7 |
IRR, inter-rater reliability; NOS, Newcastle Ottawa Scale
*Asterisk indicates item achieves one point on the NOS